Publication at Faculty of Pharmacy in Hradec Králové |
2005
Abstract
Contribution of human liver cytosolic reductases from AKR1C family is desribed to be significant in the metabolism of anti-cancer drug oracin; exclusive stereospecificity of AKR1C2 and AKR1C4 and very high stereospecificity for AKR1C1 were found